Cancer Investigation, Volume 22, Issue 2 (2004)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Cancer Investigation, Volume 22, Issue 2 (2004)

See all volumes and issues
Vol 42, 2024 Vol 41, 2023 Vol 40, 2022 Vol 39, 2021 Vol 38, 2020 Vol 37, 2019 Vol 36, 2018 Vol 35, 2017 Vol 34, 2016 Vol 33, 2015 Vol 32, 2014 Vol 31, 2013 Vol 30, 2012 Vol 29, 2011 Vol 28, 2010 Vol 27, 2009 Vol 28, 2010 Vol 27, 2009 Vol 26, 2008 Vol 25, 2007 Vol 24, 2006 Vol 23, 2005 Volume 22, 2004 Vol 21, 2003 Vol 20, 2002 Vol 19, 2001 Vol 18, 2000 Vol 17, 1999 Vol 16, 1998 Vol 15, 1997 Vol 14, 1996 Vol 13, 1995 Vol 12, 1994 Vol 11, 1993 Vol 10, 1992 Vol 9, 1991 Vol 8, 1990 Vol 7, 1989 Vol 6, 1988 Vol 5, 1987 Vol 4, 1986 Vol 3, 1985 Vol 2, 1984 Vol 1, 1983
Download citations Download PDFs Download issue

Announcement

Announcement
Announcement
Page: 1
Published online: 24 Aug 2009
CitationforAnnouncement | Full Text | PDF (33.1 KB)
  • 14 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Oxaliplatin Added to Simplified Bimonthly Low-Dose Leucovorin and 5-FU for Pretreated Advanced Colorectal Cancer Is Effective and Not Affected by Different Previous 5-FU Regimens
Ruey-Kuen Hsieh M.D., Tsu-Yi Chao M.D., Wei-Shon Chen M.D., Tsai-Shen Yang M.D., Li-Tzong Chen M.D., Po-Min Chen M.D. & Jin-Hwang Liu M.D.
Pages: 171-179
Published online: 24 Aug 2009
AbstractforOxaliplatin Added to Simplified Bimonthly Low-Dose Leucovorin and 5-FU for Pretreated Advanced Colorectal Cancer Is Effective and Not Affected by Different Previous 5-FU Regimens | Full Text | References | PDF (184.4 KB)
  • 31 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Usefulness of FDG-PET to Detect Recurrent Cervical Cancer Based on Asymptomatically Elevated Tumor Marker Serum Levels—A Preliminary Report
Wei C. Chang M.D., Yao C. Hung M.D., Cheng C. Lin M.D., Yeh Y. Shen M.D. & Chia-Hung Kao M.D.
Pages: 180-184
Published online: 24 Aug 2009
AbstractforUsefulness of FDG-PET to Detect Recurrent Cervical Cancer Based on Asymptomatically Elevated Tumor Marker Serum Levels—A Preliminary Report | Full Text | References | PDF (310.7 KB)
  • 38 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Correlation Between MIB1-Determined Tumor Growth Fraction and Incidence of Tumor Recurrence in Early Ovarian Carcinomas
Karsten Münstedt M.D., Richard von Georgi & Folker E. Franke M.D.
Pages: 185-194
Published online: 24 Aug 2009
AbstractforCorrelation Between MIB1-Determined Tumor Growth Fraction and Incidence of Tumor Recurrence in Early Ovarian Carcinomas | Full Text | References | PDF (377.2 KB)
  • 38 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Prognostic Value of PCNA and Mutant p53 Expression in Laryngeal Squamous Cell Carcinoma
Huseyin Buyukbayram M.D., Sebahattin Cureoglu M.D., Adem Arslan M.D. & A. Rahman Işikakdogan M.D.
Pages: 195-202
Published online: 24 Aug 2009
AbstractforPrognostic Value of PCNA and Mutant p53 Expression in Laryngeal Squamous Cell Carcinoma | Full Text | References | PDF (433 KB)
  • 37 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Pre- and Postoperative Aminoacidemia in Breast Cancer: A Study vs. Matched Healthy Subjects
Régine Minet-Quinard Ph.D.Pharm.D., Isabelle Van Praagh Ph.D., Fabrice Kwiatkowski Ph.D., Guy Beaujon Ph.D.Pharm.D., Viviane Feillel M.D., Bernard Beaufrère Ph.D.M.D., Pierre-Jean Bargnoux Ph.D.Pharm.D., Luc Cynober Ph.D.Pharm.D. & Marie-Paule Vasson Ph.D.Pharm.D.
Pages: 203-210
Published online: 24 Aug 2009
AbstractforPre- and Postoperative Aminoacidemia in Breast Cancer: A Study vs. Matched Healthy Subjects | Full Text | References | PDF (269.6 KB)
  • 31 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Estrogen Receptor βΔ6 (ERβΔ6) Isoform in Human Endometrial Hyperplasia and Adenocarcinoma
Monika Paul, Krzysztof Cholewa, Urszula Mazurek, Andrzej Witek & Tadeusz Wilczok
Pages: 211-218
Published online: 24 Aug 2009
AbstractforEstrogen Receptor βΔ6 (ERβΔ6) Isoform in Human Endometrial Hyperplasia and Adenocarcinoma | Full Text | References | PDF (628.8 KB)
  • 30 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Comparative Study of the Immunohistochemical Phenotype in Breast Cancer and Its Lymph Node Metastatic Location
Juan R. De la Haba-Rodríguez M.D.Ph.D., Manuel Ruiz Borrego M.D.Ph.D., Auxiliadora Gómez España M.D.Ph.D., Carlos Villar Pastor M.D., Miguel A. Japón M.D., Paulino Travado M.D., José Andrés Moreno Nogueira M.D., Fernando López Rubio M.D. & Enrique Aranda Aguilar M.D.
Pages: 219-224
Published online: 24 Aug 2009
AbstractforComparative Study of the Immunohistochemical Phenotype in Breast Cancer and Its Lymph Node Metastatic Location | Full Text | References | PDF (815.7 KB)
  • 48 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Merging Claims Databases with a Tumor Registry to Evaluate Variations in Cancer Mortality: Results from a Pilot Study of 698 Colorectal Cancer Patients Treated at One Hospital in the 1990s
Simon P. Kim M.P.H., Joseph Feinglass Ph.D., Charles L. Bennett Ph.D.M.D., Tom Lyons Ph.D., Cassie Simon C.T.R., Matthew N. Weinberg B.A. & Mark S. Talamonti M.D.
Pages: 225-233
Published online: 24 Aug 2009
AbstractforMerging Claims Databases with a Tumor Registry to Evaluate Variations in Cancer Mortality: Results from a Pilot Study of 698 Colorectal Cancer Patients Treated at One Hospital in the 1990s | Full Text | References | PDF (191 KB)
  • 43 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
In Vitro Proliferation of Fibrosarcoma Cells Depends on Intact Functions of Lipoxygenases and Cytochrome P-450-Monooxygenase
Zuzana Hoferová Ph.D., Karel Souček, Jiřina Hofmanová Ph.D., Michael Hofer Ph.D., Kateřina Chramostová, Peter Fedoročko Ph.D. & Alois Kozubik Ph.D.
Pages: 234-247
Published online: 24 Aug 2009
AbstractforIn Vitro Proliferation of Fibrosarcoma Cells Depends on Intact Functions of Lipoxygenases and Cytochrome P-450-Monooxygenase | Full Text | References | PDF (1.2 MB)
  • 15 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Expression of BAG-1 and BcL-2 Proteins Before and After Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer
Lajos Pusztai D.Phil.M.D., Savitri Krishnamurti M.D., Jorge Perez Cardona M.D., Nour Sneige M.D., Francisco J. Esteva Ph.D.M.D., Marina Volchenok M.S., Patricia Breitenfelder M.S., Shu-Wan Kau M.S., Shin Takayama M.D., Stanislaw Krajewski M.D., John C. Reed Ph.D.M.D., Robert C. Bast Jr. M.D. & Gabriel N. Hortobagyi M.D.
Pages: 248-256
Published online: 24 Aug 2009
AbstractforExpression of BAG-1 and BcL-2 Proteins Before and After Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer | Full Text | References | PDF (614.1 KB)
  • 51 Views
  • 20 CrossRef citations
  • 0Altmetric

Brief Clinical Report

Brief Report
ANNA-2: An Antibody Associated with Paraneoplastic Opsoclonus in a Patient with Large-Cell Carcinoma of the Lung with Neuroendocrine Features—Correlation of Clinical Improvement with Tumor Response
Rodrigo Erlich M.D., Candis Morrison C.R.N.P.Ph.D., Bong Kim M.D., Mark R. Gilbert M.D. & Saadah Alrajab M.D.
Pages: 257-261
Published online: 24 Aug 2009
AbstractforANNA-2: An Antibody Associated with Paraneoplastic Opsoclonus in a Patient with Large-Cell Carcinoma of the Lung with Neuroendocrine Features—Correlation of Clinical Improvement with Tumor Response | Full Text | References | PDF (557.1 KB)
  • 71 Views
  • 20 CrossRef citations
  • 0Altmetric

Radiation Oncology

Article
The Application of Number Needed to Treat (NNT) to Clinical Problems in Radiotherapy
Ashesh B. Jani M.S.E.E.M.D., Leon Myrianthopoulos Ph.D. & Srinivasan Vijayakumar M.D.
Pages: 262-270
Published online: 24 Aug 2009
AbstractforThe Application of Number Needed to Treat (NNT) to Clinical Problems in Radiotherapy | Full Text | References | PDF (136.6 KB)
  • 25 Views
  • 4 CrossRef citations
  • 0Altmetric

Clinical Trial

Article
Role of COX-2 Inhibitors in Cancer Therapy
Charles Blanke F.A.C.P.M.D.
Pages: 271-282
Published online: 24 Aug 2009
First Page PreviewforRole of COX-2 Inhibitors in Cancer Therapy | Full Text | References | PDF (150.5 KB)
  • 48 Views
  • 19 CrossRef citations
  • 0Altmetric

Concise Reviews in Surgery

Review Article
Surgical Management of Hepatic Malignancy
David A. Kooby M.D. & William R. Jarnagin FACSM.D.
Pages: 283-303
Published online: 24 Aug 2009
AbstractforSurgical Management of Hepatic Malignancy | Full Text | References | PDF (803.3 KB)
  • 41 Views
  • 12 CrossRef citations
  • 0Altmetric

New Drugs

Article
Development of the Proteasome Inhibitor Velcade™ (Bortezomib)
Julian Adams Ph.D. & Michael Kauffman Ph.D.M.D.
Pages: 304-311
Published online: 24 Aug 2009
AbstractforDevelopment of the Proteasome Inhibitor Velcade™ (Bortezomib) | Full Text | References | PDF (766.3 KB)
  • 2587 Views
  • 493 CrossRef citations
  • 0Altmetric

Journal as a University—Course 004: Pathology Course Chair: J. A. Strauchen, M.D.

Article
Impact of Microarray Technology in Clinical Oncology
Elizabeth A. Raetz Ph.D. & Philip J. Moos Ph.D.
Pages: 312-320
Published online: 24 Aug 2009
AbstractforImpact of Microarray Technology in Clinical Oncology | Full Text | References | PDF (202.7 KB)
  • 22 Views
  • 19 CrossRef citations
  • 0Altmetric

Editorial

Article
Evidence-Based Oncology
A. Robert Kagan M.D.
Pages: 321-323
Published online: 24 Aug 2009
First Page PreviewforEvidence-Based Oncology | Full Text | References | PDF (83.8 KB)
  • 21 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
COX-2 Inhibitors as Cancer Treatment: Will They Be the New Warfarin or Trastuzumab?
James Liebmann M.D.
Pages: 324-325
Published online: 24 Aug 2009
First Page PreviewforCOX-2 Inhibitors as Cancer Treatment: Will They Be the New Warfarin or Trastuzumab? | Full Text | References | PDF (78.7 KB)
  • 28 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Hospital Information Systems and Clinical Cancer Research
Alfred I. Neugut Ph.D.M.D.
Pages: 326-327
Published online: 24 Aug 2009
First Page PreviewforHospital Information Systems and Clinical Cancer Research | Full Text | References | PDF (76.2 KB)
  • 8 Views
  • 0 CrossRef citations
  • 0Altmetric
Editorial
“Development of the Proteasome Inhibitor Velcade™ (Bortezomib)” by Julian Adams, Ph.D., and Michael Kauffman, M.D., Ph.D
Richard Bold M.D.
Pages: 328-329
Published online: 24 Aug 2009
First Page Previewfor“Development of the Proteasome Inhibitor Velcade™ (Bortezomib)” by Julian Adams, Ph.D., and Michael Kauffman, M.D., Ph.D | Full Text | References | PDF (76.1 KB)
  • 821 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access

Explore articles